Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mixed Analyst Opinions on WW Graingers Price Target

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
DVY stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Chris Snyder of UBS has decided to keep W.W. Grainger at a Neutral rating but has raised the price target significantly from $740 to $1000. This differs from fellow UBS analyst Joseph Parkhill, who downgraded W.W. Grainger from Buy to Neutral but only increased the price target slightly from $815 to $820. The average 12-month price target for W.W. Grainger sits at $926.50, according to analyst ratings. Oppenheimer has set the latest price target for W.W. Grainger at $1000, anticipating a 14.36% increase within the next year. Overall, analysts seem to agree on a Hold rating for W.W. Grainger, with a mix of opinions contributing to this consensus.

Grainger (GWW) Stock Shows Strong Performance, Trading Near 52-Week High

On March 14, 2024, Grainger (GWW) stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates positive price momentum for the stock. The price of GWW shares increased by $12.10 since the market last closed, representing a 1.24% rise. The stock opened at $1.02K, which was $42.15 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects on that day. Grainger is a leading distributor of industrial supplies, with a strong track record of serving businesses across various industries. Investors should keep an eye on GWW stock as it continues to demonstrate positive price momentum and potentially offers opportunities for further gains.

Grainger (GWW) Stock Performance Analysis: Revenue Up, Net Income Down

On March 14, 2024, Grainger (GWW) stock saw some fluctuations in its performance based on the latest financial data released by the company. The total revenue for the past year stood at $16.48 billion, showing an increase of 8.21% compared to the previous year. However, the total revenue for the fourth quarter was reported at $4.00 billion, which represented a decrease of 5.01% compared to the previous quarter.

The net income for the past year was reported at $1.83 billion, showing an increase of 18.23% compared to the previous year. On the other hand, the net income for the fourth quarter was reported at $395.00 million, which represented a decrease of 17.02% compared to the previous quarter.

Earnings per share (EPS) for the past year were reported at $36.51, showing an increase of 20.59% compared to the previous year. However, the EPS for the fourth quarter remained flat at $7.95.

Overall, the financial performance of Grainger (GWW) showed mixed results for the past year and the fourth quarter. While there were significant increases in net income and earnings per share compared to the previous year, there were decreases in total revenue and net income compared to the previous quarter.

Investors and analysts may be closely monitoring these financial indicators to assess the future performance and potential growth prospects of Grainger (GWW) stock.

Tags: GWW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Advancing Chronic Kidney Disease Management through Genetic Testing Natera Endorses 2024 KDIGO Clinical Practice Guideline

Biotechnology Trading online

Ascendis Pharma A Remarkable Investment Success Story

Healthcare-and-IT

Grifols Focuses on Deleveraging Strategy for Enhanced Financial Performance

Recommended

Unum Stock

Unum’s Strategic Pivot Amid Mixed Quarterly Performance

2 weeks ago
DexCom Stock

DexCom Stock: Growth Slows Despite Positive Earnings

2 months ago
First Busey Stock

A Regional Bank’s Quiet Ascent: First Busey Gains Institutional Favor

3 weeks ago

The Enchanting World of Waverley Country Club A Cinematic Experience

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Berkshire Hathaway Concludes 17-Year BYD Investment with Complete Exit

Analysts Defend SAP’s Market Position Against Oracle Competition

Deutsche Bank Rejoins Europe’s Premier Index After Seven-Year Absence

Ethereum’s Quiet Ascent: The Calm Before the Next Rally

Espionage Scandal Rocks Austrian Energy Giant OMV

Siemens Energy Stock Surges Following Prestigious Index Inclusion

Trending

Deutz AG Stock
Analysis

Defense Sector Momentum Could Propel Deutz AG’s Strategic Growth

by Felix Baarz
September 22, 2025
0

Deutz AG appears strategically positioned at a potential inflection point. The engine manufacturer's recent moves to strengthen...

Valneva Stock

Valneva Shares Face Regulatory Setback Despite Promising Pipeline

September 22, 2025
Rheinmetall Stock

Strategic Naval Acquisition Positions Rheinmetall for Broader Defense Dominance

September 22, 2025
BYD Stock

Berkshire Hathaway Concludes 17-Year BYD Investment with Complete Exit

September 22, 2025
SAP Stock

Analysts Defend SAP’s Market Position Against Oracle Competition

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Defense Sector Momentum Could Propel Deutz AG’s Strategic Growth
  • Valneva Shares Face Regulatory Setback Despite Promising Pipeline
  • Strategic Naval Acquisition Positions Rheinmetall for Broader Defense Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com